Latest antibodies Stories
MONROVIA, Calif., March 24, 2014 /PRNewswire/ -- Xencor, Inc.
Telephus Advances TPH 101 Program Towards Candidate Selection SAN DIEGO, March 18, 2014 /PRNewswire/ -- BioAtla, a global biotechnology company focused on the development of differentiated
CAMBRIDGE, England, March 16, 2014 /PRNewswire/ -- Kymab, a monoclonal antibody biopharmaceutical company founded on research from the Wellcome Trust
DUBLIN, March 13, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/43nvqj/cancer_monoclonal) has announced the addition of the "Cancer
MONROVIA, Calif., March 13, 2014 /PRNewswire/ -- Xencor, Inc.
SAN DIEGO, March 13, 2014 /PRNewswire/ -- AnaptysBio, Inc., a leader in the discovery and development of therapeutic antibodies, today announced a strategic immuno-oncology collaboration
AUSTIN, Texas, March 11, 2014 /PRNewswire/ -- XBiotech announced today that the United States Patent and Trademark Office (USPTO) granted another key patent to support the Company's growing
DUBLIN, March 5, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/r8hfhg/fc_protein_and) has announced the addition of the "Fc Protein
- Monstrous in size or character; huge; prodigious; monstrously perverse, savage, cruel, etc.
More Images (1 images) »